Published in Osteoarthritis Cartilage on November 01, 2001
Processing of type I collagen gels using nonenzymatic glycation. J Biomed Mater Res A (2010) 0.97
The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuli. J Immunol (2009) 0.93
Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage. Arthritis Res Ther (2012) 0.93
Joint aging and chondrocyte cell death. Int J Clin Rheumtol (2010) 0.86
Life-long endurance running is associated with reduced glycation and mechanical stress in connective tissue. Age (Dordr) (2014) 0.83
Evaluation of prolidase activity and oxidative status in patients with knee osteoarthritis: relationships with radiographic severity and clinical parameters. Rheumatol Int (2015) 0.83
Curcumin and tetrahydrocurcumin both prevent osteoarthritis symptoms and decrease the expressions of pro-inflammatory cytokines in estrogen-deficient rats. Genes Nutr (2016) 0.78
Consequences of metabolic and oxidative modifications of cartilage tissue. Nat Rev Rheumatol (2015) 0.77
Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case-control study. Br J Clin Pharmacol (2015) 0.76
Severity of Diabetes Mellitus and Total Hip or Knee Replacement: A Population-Based Case-Control Study. Medicine (Baltimore) (2016) 0.75
Pentosidine, an advanced glycation end-product, may reflect clinical and morphological features of hand osteoarthritis. Open Rheumatol J (2012) 0.75
RAGE, receptor of advanced glycation endoproducts, negatively regulates chondrocytes differentiation. PLoS One (2014) 0.75
Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age. Rejuvenation Res (2013) 0.75
O-GlcNAcylation: a bridge between glucose and cell differentiation. J Cell Mol Med (2016) 0.75
Inhibitory effect of JAK inhibitor on mechanical stress-induced protease expression by human articular chondrocytes. Inflamm Res (2017) 0.75
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial. Ann Intern Med (1996) 3.75
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann Rheum Dis (2004) 3.64
Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem (2000) 3.17
CREB: a major mediator of neuronal neurotrophin responses. Neuron (1997) 3.04
Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial. Ann Oncol (2004) 2.97
The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl J Med (1998) 2.90
[Safety of specific cyclo-oxygenase 2 inhibitors]. Ned Tijdschr Geneeskd (2001) 2.76
EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 2.75
Pain and disability in patients with osteoarthritis of hip or knee: the relationship with articular, kinesiological, and psychological characteristics. J Rheumatol (1998) 2.33
Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review of randomized clinical trials. Arthritis Rheum (1999) 2.27
Carpal tunnel sonography by the rheumatologist versus nerve conduction study by the neurologist. J Rheumatol (2001) 2.24
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases. Ann Oncol (2003) 2.16
EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis (2008) 2.15
Effectiveness of exercise in patients with osteoarthritis of hip or knee: nine months' follow up. Ann Rheum Dis (2001) 2.04
[Classification of fibromyalgia: criteria of the American College of Rheumatology]. Ned Tijdschr Geneeskd (1992) 2.03
Mechanical properties of the collagen network in human articular cartilage as measured by osmotic stress technique. Arch Biochem Biophys (1998) 2.00
The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis Rheum (2000) 1.97
EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis (2009) 1.95
Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psychol (2001) 1.91
The effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a randomized clinical trial. J Rheumatol (1998) 1.84
Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum (1996) 1.76
[Gout: current aspects of etiology, diagnosis and therapy]. Ned Tijdschr Geneeskd (1996) 1.72
Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci (1999) 1.67
The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol (2000) 1.61
Range of joint motion and disability in patients with osteoarthritis of the knee or hip. Rheumatology (Oxford) (2000) 1.60
European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis (2011) 1.59
Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus. Ann Rheum Dis (1998) 1.55
The role of collagen in determining bone mechanical properties. J Orthop Res (2001) 1.48
Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis (1994) 1.47
Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol (2001) 1.46
Articular cartilage is more susceptible to blood induced damage at young than at old age. J Rheumatol (2000) 1.45
Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet (1991) 1.45
Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum (1995) 1.44
Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J (2000) 1.43
A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol (1997) 1.42
Diabetic ketoacidosis associated with risperidone treatment? Psychosomatics (2000) 1.41
Sweet's syndrome. Neth J Med (1990) 1.40
Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci U S A (1999) 1.39
[Calcium pyrophosphate arthropathy: more than chondrocalcinosis and pseudogout]. Ned Tijdschr Geneeskd (1992) 1.39
Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum (1999) 1.39
[Pharmacotherapy of patients with (early) rheumatoid arthritis]. Ned Tijdschr Geneeskd (2000) 1.39
['Stomach-friendly' NSAIDs: careful optimism?]. Ned Tijdschr Geneeskd (1995) 1.39
Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run. J Chromatogr B Biomed Sci Appl (1997) 1.38
Sonography and magnetic resonance imaging equivalent for the assessment of full-thickness rotator cuff tears. Arthritis Rheum (1999) 1.36
Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum (1996) 1.35
Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J (1999) 1.33
Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant (2005) 1.33
Pain and disability in osteoarthritis: a review of biobehavioral mechanisms. J Behav Med (1992) 1.32
A comparative analysis of bone and cartilage metabolism in two strains of guinea-pig with varying degrees of naturally occurring osteoarthritis. Osteoarthritis Cartilage (2002) 1.32
Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Ann Rheum Dis (1993) 1.29
Comparison of sonography and magnetic resonance imaging for the diagnosis of partial tears of finger extensor tendons in rheumatoid arthritis. Rheumatology (Oxford) (2000) 1.29
MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis (2005) 1.27
Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis (2003) 1.26
The increased swelling and instantaneous deformation of osteoarthritic cartilage is highly correlated with collagen degradation. Arthritis Rheum (2000) 1.24
Compositional and metabolic changes in damaged cartilage are peak-stress, stress-rate, and loading-duration dependent. J Orthop Res (1999) 1.23
Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis Cartilage (2003) 1.23
Effects of rheumatoid arthritis on employment and social participation during the first years of disease in The Netherlands. Br J Rheumatol (1998) 1.20
MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.19
Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis (1996) 1.18
Muscle strength, pain and disability in patients with osteoarthritis. Clin Rehabil (2001) 1.14
Long-term course of tear gland function in patients with keratoconjunctivitis sicca and Sjögren's syndrome. Br J Ophthalmol (1997) 1.13
Physical and psychosocial disability in elderly subjects in relation to pain in the hip and/or knee. J Rheumatol (1996) 1.13
Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands. Ann Rheum Dis (2000) 1.13
Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. Semin Arthritis Rheum (1999) 1.11
Bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis. Ann Rheum Dis (1986) 1.10
Specific enzymatic treatment of bovine and human articular cartilage: implications for integrative cartilage repair. Arthritis Rheum (2002) 1.09
Pathogenesis of haemophilic arthropathy. Haemophilia (2006) 1.08
Psychosocial predictors of functional change in recently diagnosed rheumatoid arthritis patients. Behav Res Ther (1998) 1.08
Can Ilizarov joint distraction delay the need for an arthrodesis of the ankle? A preliminary report. J Bone Joint Surg Br (1995) 1.07
[Diagnosis and treatment of gout: not always simple]. Ned Tijdschr Geneeskd (1996) 1.07
Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease. Ann Rheum Dis (1997) 1.07
Corticosteroid pulse therapy in active rheumatoid arthritis. Semin Arthritis Rheum (1993) 1.06
Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum (2001) 1.06
The pattern of health care utilization of elderly people with arthritic pain in the hip or knee. Int J Qual Health Care (1997) 1.05
The canine 'groove' model, compared with the ACLT model of osteoarthritis. Osteoarthritis Cartilage (2002) 1.05
Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis (1995) 1.05
Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer. Eur J Cancer (2004) 1.04
Role of TNF alpha, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage. Br J Rheumatol (1991) 1.03